Expression and characterization of the chemokine receptor CCR2B from rhesus monkey

Biochemical Pharmacology

Volumn 66, Issue 2, 2003, Pages 321-330

  Jin, Hong ^a   Vicario, Pasquale P ^a   Zweerink, Hans ^a   Goyal, Shefali ^a   Hanlon, William A ^a   Dorn, Conrad P ^a   Mills, Sander G ^a   DeMartino, Julie A ^a   Cascieri, Margaret A ^a   Struthers, Mary ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antagonist; CCR2B; Chemokine; MCP 1; Receptor; Rhesus monkey

Indexed keywords

CALCIUM; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; EOTAXIN; GENOMIC DNA; IODINE 125; LIGAND; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; TAK 799;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHO CELL; CONTROLLED STUDY; DRUG POTENCY; FLOW CYTOMETRY; GENOMICS; HUMAN; HUMAN CELL; LIGAND BINDING; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RHESUS MONKEY;

EID: 0038094525     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00245-4     Document Type: Article

References (37)

1. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. New Engl. J. Med. 338:1998;436-445.
2. Katschke K.J.J., Rottman J.B., Ruth J.H., Zin S., Wu L., LaRosa G., Ponath P., Park C.C., Pope R.M., Koch A.E. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 44:2001;1022-1032.
3. Moore U.M., Kaplow J.M., Pleass R.D., Castro S.W., Naik K., Lynch C.N., Daly S., Roach A.G., Jaye M., Williams R.J. Monocyte chemoattractant protein-2 is a potent agonist of CCR2B. J. Leukoc. Biol. 62:1997;911-915.
4. Sozzani S., Zhou D., Locati M., Pieppi M., Proost P., Magazin M., Vita N., Damme J.V., Mantovani A. Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3: similarities and differences with MCP-1. J. Immunol. 152:1994;3615-3622.
5. Myers S.J., Wong L.M., Charo I.F. Signal transduction and ligand specificity of the human monocyte chemoattractant protein-1 receptor in transfected embryonic kidney cells. J. Biol. Chem. 270:1995;5786-5792.
6. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein-1-deficient mice. J. Exp. Med. 187:1998;601-608.
7. Kuziel W.A., Morgan S.J., Dawson T.C., Griffin S., Smithies O. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12053-12058.
8. Kurihara T., Warr G., Loy J., Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186:1997;1757-1762.
9. Boring L., Gosling J., Chensue S., Kunkel S.L., Farese R.V.J., Broxmeyer H.E. impaired monocyte migration and reduced type-1 (TH1) cytokine responses in C-C chemokine receptor knockout mice. J. Clin. Invest. 100:1997;2552-2561.
10. Yanni G., Whelan A., Feighery C., Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann. Rheum. Dis. 53:1994;39-44.
11. Feldmann M, Brennan RM, Foxwell BMJ, Maini RN. The role of TNFα and IL-1 in rheumatoid arthritis. In: Goronzy JJ, Weyand CM, editors. Rheumatoid arthritis. Curr Dir Autoimmun. Basel: Karger; 2001. p. 188-99.
12. Shapiro S.D. The macrophage in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160:1999;S29-S32.
13. Zhu Z, Ma B, Zheng T, Homer RJ, Lee CG, Charo IF, Noble P, Elias JA. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 2002;168:2953-62.
14. Plenz G., Robenek H. Monocytes/macrophages in atherosclerosis. Eur. Cytokine Netw. 9:1998;701-704.
15. Dawson T.C., Kuziel W.A., Osahar T.A., Maeda N. Absence of CC chemokine recpetor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 143:1999;205-211.
16. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.
17. Brok H.P., Pekoppele J.M., Hakimi J., Kerwin J.A., Nijenhuis E.M., De Groot C.W., Bontrop R.E., t'Hart B.A. Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys. Clin. Exp. Immunol. 124:2001;134-141.
18. t'Hart B.A., Bank R.A., De Roos J.A., Brok J., Jonker M., Theuns H.M., Hakimi J., Te Koppele J.M. Collagen-induced arthritis in rhesus monkeys: evaluation of markers for inflammation and joint degradation. Br. J. Rheumatol. 37:1998;314-323.
19. Brok H.P., Bauer J., Jonker M., Blezer E., Amor S., Bontrop R., Laman J.D., t'Hart B.A. Non-human primate models of multiple sclerosis. Immunol. Rev. 183:2001;173-185.
20. Knechtle S.J., Vargo D., Fchner J., Zhai Y., Wang J., Hanaway M.J., Scharff J., Hu H., Knapp L., Watkins D., Neville D.M.J. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation. 63:1997;1-6.
21. Kirk A.D., Harlan D.M., Armstrong N.N., Davis T.A., Dong Y., Gray G.S., Hong X., Thomas D., Fechner J.H.J., Knechtle S.J. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. U.S.A. 94:1997;8769-8794.
22. Fritz D.L., Jaax N.K., Lawrence W.B., Davis K.J., Pitt M.L., Ezzell J.W., Friedlander A.M. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab. Invest. 73:1995;691-702.
23. England J.D., Bohm R.P.J., Roberts E.D., Phillipp M.T. Lyme neuroborreliosis in the rhesus monkey. Semin. Neurol. 17:1997;53-56.
24. Baba M., Nishimura O., Kanzaki N., Okamoto M., Sawada H., Iizawa Y., Shiraishi M., Aeamaki Y., Okonogi K., Ogawa Y., Meguro K., Fujino M. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV activity. Proc. Natl. Acad. Sci. U.S.A. 96:1999;5698-5703.
25. Margulies B.J., Hauer D.A., Clements J.E. Identification and comparison of eleven rhesus macaque chemokine receptors. AIDS Res. Hum. Retroviruses. 17:2001;981-986.
26. Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 266:1991;19867-19870.
27. Daugherty B.L., Siciliano S.L., DeMartino J.A., Malkowitz L., Sirotina A., Springer M.S. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 177:1996;851-856.
28. Ayala J.A., Goyal S., Liverton N.J., Caremon D.A., O'Keefe S.J., Hanoln W.A. Serum-induced monoycte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway. J. Leukoc. Biol. 67:2000;869-875.
29. Dragic T., Trkola A., Daniah A.D., Thompson D.A.D., Cormier E.G., Kajumo F.A., Maxwell E., Lin S.W., Ying W., Smith S.O., Sakmar T.P., Moore J.P. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc. Natl. Acad. Sci. U.S.A. 97:2000;5639-5644.
30. Bikker J.A., Trumpp-Kallmeyer S., Humblet C. G-protein coupled receptors: models, mutagenesis, and drug design. J. Med. Chem. 41:1998;2911-2927.
31. Strader C.D., Fong T.M., Graziano M.P., Tota M.R. The family of G-protein-coupled receptors. FASEB J. 9:1995;745-754.
32. Proudfoot A.E.I. Chemokine receptors: mulitfaceted therapeutic targets. Nat. Rev. Immunol. 2:2002;106-115.
33. Samson M., LaRosa G., Libert F., Paindavoine P., Detheux M., Vassart G., Parmentier M. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. 272:1997;24934-24941.
34. Franci C., Wong L.M., Damme J.V., Proost P., Charo I.F. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor. J. Immunol. 154:1995;6511-6517.
35. Kurihara T., Bravo R. Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC. J. Biol. Chem. 271:1996;11603-11606.
36. Ogilvie P., Bardi G., Clark-Lewis I., Baggiolini M., Uguccioni M. Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood. 97:2001;1920-1924.
37. Martinelli R., Sabroe I., LaRosa G., Williams T.J., Pease J.E. The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b. J. Biol. Chem. 276:2001;42957-42964.